학술논문

PRECLINICAL AND CLINICAL CHARACTERIZATION OF CENERIMOD, A POTENT, SELECTIVE, AND ORALLY ACTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 MODULATOR IN SLE
Document Type
Journal
Source
ANNALS OF THE RHEUMATIC DISEASES; JUN 2020, 79 p1019-p1019, 1p. Supplement: 1
Subject
Language
English
ISSN
14682060